8-K/A

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K/A

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): August 4, 2015

 

 

Gevo, Inc.

(Exact Name of Registrant as Specified in Charter)

 

 

 

Delaware   001-35073   87-0747704

(State or Other Jurisdiction of

Incorporation)

 

Commission

File Number

 

(I.R.S. Employer

Identification Number)

345 Inverness Drive South,

Building C, Suite 310, Englewood, CO 80112

(Address of Principal Executive Offices) (Zip Code)

Registrant’s telephone number, including area code: (303) 858-8358

N/A

(Former Name, or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 2.02. Results of Operations and Financial Condition.

On August 4, 2015, Gevo, Inc. (the “Company”) issued a press release announcing the Company’s second quarter 2015 financial results. This press release contained an error related to the calculation of the Company’s non-cash loss related to inducement payments made in connection with exercises of warrants to purchase shares of the Company’s common stock issued in December 2013 and August 2014. As a result, the Company’s net loss for the second quarter of 2015 was overstated by $3.4 million.

To correct this error, we are revising the information we provided in the press release we issued on August 4, 2015 as follows:

Financial Highlights

Reports EPS of ($1.10) for the second quarter

During the three months ended June 30, 2015, a $1.8 million non-cash gain was recognized from inducement payments made in connection with exercises of warrants to purchase shares of the Company’s common stock issued in December 2013 and warrants to purchase shares of the Company’s common stock issued in August 2014. This is the result of the fair value of the derivative warrant liability plus cash received for the warrants being greater than the fair value of the shares issued upon exercise.

The net loss for the second quarter of 2015 was $14.4 million, compared with $17.2 million during the same period in 2014.


Gevo, Inc.

Condensed Consolidated Statements of Operations Information

(Unaudited, in thousands, except share and per share amounts)

 

     Three Months Ended June 30,     Six Months Ended June 30,  
     2015     2014     2015     2014  

Revenue and cost of goods sold

        

Ethanol sales and related products, net

   $ 7,955      $ 5,522      $ 13,053      $ 5,522   

Hydrocarbon revenue

     740        2,018        1,257        2,648   

Grant and other revenue

     229        181        513        454   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total revenues

     8,924        7,721        14,823        8,624   
  

 

 

   

 

 

   

 

 

   

 

 

 

Cost of goods sold

     9,898        8,269        19,132        12,949   
  

 

 

   

 

 

   

 

 

   

 

 

 

Gross loss

     (974     (548     (4,309     (4,325
  

 

 

   

 

 

   

 

 

   

 

 

 

Operating expenses

        

Research and development

     1,765        3,586        3,487        7,691   

Selling, general and administrative

     3,792        4,898        8,271        9,938   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     5,557        8,484        11,758        17,629   
  

 

 

   

 

 

   

 

 

   

 

 

 

Loss from operations

     (6,531     (9,032     (16,067     (21,954
  

 

 

   

 

 

   

 

 

   

 

 

 

Other income (expense)

        

Interest expense

     (2,029     (2,609     (4,064     (4,210

Interest expense - debt issue costs

     —          (3,185     —          (3,185

Gain on conversion of debt

     —          —          285        —     

Gain on extinguishment of warrant liability

     1,775        —          1,775        —     

Gain from change in fair value of embedded derivatives of the 2022 Notes

     —          1,480        —          2,744   

Gain (loss) from change in fair value of 2017 Notes

     (340     (5,129     3,425        (5,129

Gain (loss) from change in fair value of derivative warrant liability

     (7,247     1,321        (7,080     2,599   

Other income

     2        (2     13        7   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total other expense

     (7,839     (8,124     (5,646     (7,174
  

 

 

   

 

 

   

 

 

   

 

 

 

Net loss

   $ (14,370   $ (17,156   $ (21,713   $ (29,128
  

 

 

   

 

 

   

 

 

   

 

 

 

Net loss per share attributable to Gevo, Inc. common stockholders - basic and diluted

   $ (1.10   $ (3.79   $ (2.03   $ (6.44
  

 

 

   

 

 

   

 

 

   

 

 

 

Weighted-average number of common shares outstanding - basic and diluted

     13,009,434        4,531,321        10,673,891        4,524,390   


Gevo, Inc.

Condensed Consolidated Cash Flow Information

(Unaudited, in thousands)

 

     Six Months Ended
June 30,
 
     2015     2014  

Operating Activities

    

Net loss

   $ (21,713   $ (29,128

Adjustments to reconcile net loss to net cash used in operating activities:

    

Gain from change in fair value of derivative warrant liability

     7,080        (2,599

Gain from change in fair value of embedded derivative of 2022 Notes

     —          (2,744

Gain from change in fair value of 2017 Notes

     (3,425     5,129   

Gain on conversion of debt

     (285     —     

Gain on extinguishment of warrant liability

     (1,775     —     

Stock-based compensation

     698        1,503   

Depreciation and amortization

     3,281        1,604   

Non-cash interest expense

     1,767        5,365   

Changes in operating assets and liabilities:

    

Accounts receivable

     42        (1,727

Inventories

     1,389        (661

Prepaid expenses and other current assets

     160        228   

Deposits and other assets

     —          (31

Accounts payable, accrued expenses, and long-term liabilities

     (2,104     (2,159
  

 

 

   

 

 

 

Net cash used in operating activities

     (14,885     (25,220
  

 

 

   

 

 

 

Investing Activities

    

Acquisitions of property, plant and equipment

     (175     (3,837

Proceeds from sales tax refund for property, plant and equipment

     144        —     

Restricted certificate of deposit

     —          (2,611
  

 

 

   

 

 

 

Net cash used in investing activities

     (31     (6,448
  

 

 

   

 

 

 

Financing Activities

    

Payments on secured debt

     (131     (9,622

Debt and equity offering costs

     (2,785     (3,352

Proceeds from issuance of common stock upon exercise of stock options and employee purchase plan

     —          19   

Proceeds from issuance of common stock and common stock units

     23,850        —     

Proceeds from exercise of warrants

     10,151        —     

Proceeds from issuance of convertible debt

     —          25,906   
  

 

 

   

 

 

 

Net cash provided by financing activities

     31,085        12,951   
  

 

 

   

 

 

 

Net increase (decrease) in cash and cash equivalents

     16,169        (18,717

Cash and cash equivalents

    

Beginning of period

     6,359        24,625   
  

 

 

   

 

 

 

Ending of period

   $ 22,528      $ 5,908   
  

 

 

   

 

 

 


The information contained herein shall not be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing, unless expressly incorporated by specific reference to such filing. The information in this Current Report on Form 8-K/A shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Gevo, Inc.
By:   /s/ Mike Willis
  Mike Willis
  Chief Financial Officer

Date: August 7, 2015